<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Articles SYSTEM "HBI_DTD">
<Articles><Article><Journal><PublisherName></PublisherName><JournalTitle>Journal of Research in Medical Sciences</JournalTitle><Issn>1735-1995</Issn><Volume>22</Volume><Issue>11</Issue><PubDate PubStatus="epublish"><Year>2017</Year><Month>12</Month><Day>03</Day></PubDate></Journal><title locale="en_US">Effect of Nepeta bracteata Benth. on allergic rhinitis symptoms: A randomized double-blind clinical trial</title><FirstPage>10721</FirstPage><LastPage>10721</LastPage><Language>EN</Language><AuthorList><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/><Author/></AuthorList><History><PubDate PubStatus="received"><Year>2017</Year><Month>11</Month><Day>15</Day></PubDate></History><abstract locale="en_US">&lt;span class="fontstyle0"&gt;Context&lt;/span&gt;&lt;span class="fontstyle1"&gt;: Allergic rhinitis (AR) is one of the health problems in the world. It is necessary to develop new treatment procedure &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;for control of this  disease. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Aims&lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;: Te aim of this study was to assess the effect of &lt;/span&gt;&lt;span class="fontstyle3"&gt;Zofa &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;(&lt;/span&gt;&lt;span class="fontstyle3"&gt;Nepeta bracteata &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;Benth) on AR patients. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Settings and Design: &lt;/span&gt;&lt;span class="fontstyle1"&gt;???. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Materials and Methods: &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;In this double-blind randomized clinical trial study, 71 patients (37 patients in treatment and 34 in placebo group) participated. In treatment group, &lt;/span&gt;&lt;span class="fontstyle3"&gt;N. bracteata &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;syrup (NBS) was used for 4 weeks as three times a day. Te efficacy of the drug regarding AR symptoms (rhinorrhea, sneezing, nasal obstruction, itchy nose, and ocular symptoms) were evaluated through a visual analog scale (VAS) by 0–10 before administration and at the end of the whole treatment period.&lt;br /&gt;&lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Statistical Analysis Used: &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;Te collected information was entered in the SPSS software (version 18) and was analyzed using the Fisher’s exact test, Chi-square test, independent sample &lt;/span&gt;&lt;span class="fontstyle3"&gt;t&lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;-test, and paired sample test. &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Results: &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;Te improvement of AR symptoms in the group receiving NBS was significantly higher compared to control group (4.73 ± 1.84 vs. 0.38 ± 2.06; &lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;&amp;lt; 0.0001). Furthermore, the mean of total VAS before and after the treatment (in case group) was 7.10 ± 1.92 and 2.37 ± 1.76, respectively (&lt;/span&gt;&lt;span class="fontstyle3"&gt;P &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;&amp;lt; 0.001). &lt;/span&gt;&lt;span class="fontstyle0" style="color: #231f20;"&gt;Conclusion: &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;Te results of this study indicate that &lt;/span&gt;&lt;span class="fontstyle3"&gt;N. bracteata &lt;/span&gt;&lt;span class="fontstyle1" style="color: #231f20;"&gt;has significant effects on improving the symptoms of AR. Hence, it can be a good alternative to AR symptoms relief. &lt;/span&gt; &lt;br style="font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: 2; text-align: -webkit-auto; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px;" /&gt;</abstract><web_url>http://jrms.mui.ac.ir/index.php/jrms/article/view/10721</web_url><pdf_url>http://jrms.mui.ac.ir/index.php/jrms/article/download/10721/5569</pdf_url></Article></Articles>
